HeartFlow IPO
HeartFlow develops AI-powered diagnostic software that creates 3D models of coronary arteries from CT scans to assess heart disease non-invasively. The technology is FDA-cleared and used by hospitals as an alternative to invasive catheterization procedures. HeartFlow has been pursuing a public listing after a previous SPAC deal was canceled.
Key Facts
| Industry | Medical Technology |
| Founded | 2007 |
| Headquarters | Redwood City, CA |
| Employees | ~800 |
| Website | heartflow.com |
| Funding | Public company (NASDAQ: HFLO). Previously raised ~$500M |
About HeartFlow
HeartFlow has developed the HeartFlow FFRct Analysis, a non-invasive technology that creates personalized 3D models of coronary arteries from standard CT scans. This technology enables physicians to assess coronary artery disease and determine the functional significance of blockages without requiring invasive cardiac catheterization procedures. The platform uses advanced computational fluid dynamics and machine learning to analyze blood flow and identify lesions that may cause ischemia.
The company's technology has been adopted by healthcare systems worldwide and has demonstrated clinical and economic benefits by reducing unnecessary invasive procedures while improving diagnostic accuracy. HeartFlow went public on NASDAQ in 2021 and continues to expand its platform with additional cardiovascular applications. Their approach represents a significant advancement in precision medicine for cardiac care, helping physicians make more informed treatment decisions.
IPO Status
HeartFlow completed its IPO on the Nasdaq under ticker HTFL in August 2025 at $19 per share, raising $364 million. The stock opened at $28, surging over 58% on day one. HeartFlow previously had a SPAC deal that fell through before pursuing a traditional IPO.
Competitors
Frequently Asked Questions
Does HeartFlow have a stock?
Yes, HeartFlow has already gone public. The company IPO'd on the Nasdaq under ticker HTFL in August 2025 at $19 per share.
When is the HeartFlow IPO date?
HeartFlow's IPO date was August 11, 2025. The stock opened at $28, surging over 58% above its IPO price on day one.
How can I buy HeartFlow stock?
You can buy HeartFlow stock (HTFL) through any major brokerage account. The company trades on the Nasdaq.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts